ASC-41

N/A

Report date: 2026/02/07 20:00:33
NME

Base Information

Drug NameASC-41
Drug Alias NameASC-41
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta-1 agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsOverweightObesityHyperlipidemias +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAscletis Pharma (China) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGannex Pharma Co Ltd
Inactive CompaniesAscletis Pharma IncAscletis Pharmaceutical (Zhejiang) Co Ltd
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsOverweightObesityHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A